Medical Devices

July 13, 2018

Companies covered: Medtronic, Inc. (NYSE:MDT), Baxter International Inc. (NYSE:BAX), Abbott Laboratories (NYSE:ABT), Tactile Systems Technology, Inc. (NASDAQ:TCMD), DexCom, Inc. (NASDAQ:DXCM), Inogen, Inc (NASDAQ:INGN), Edwards Lifesciences Corporation (NYSE:EW), ABIOMED, Inc. (NASDAQ:ABMD), Intuitive Surgical, Inc. (NASDAQ:ISRG), Amazon.com, Inc. (NASDAQ:AMZN), VolitionRX Limited (NYSEAMERICAN:VNRX), CryoPort Inc. (NASDAQ:CYRX), Gilead Sciences, Inc. (NASDAQ:GILD), Novartis AG (NYSE:NVS), Bristol-Myers Squibb Company (NYSE:BMY), Pfizer, Inc. (NYSE:PFE), Dare Bioscience (NASDAQ:DARE), Merck & Company, Inc. (NYSE:MRK), Biomerica Inc. (NASDAQ:BMRA), Allergan, Inc. (NYSE:AGN), Hologic, Inc. (NASDAQ:HOLX), International Business Machines Corporation (NYSE:IBM), Restoration Robotics, Inc. (NASDAQ:HAIR), Cure Pharmaceutical Holding Corp. (OTCMKTS:CURR), Motus GI Holdings, Inc. (NASDAQ:MOTS), Co-Diagnostics, Inc. (NASDAQ:CODX), electroCore, Inc. (NASDAQ:ECOR), ReWalk Robotics Ltd (NASDAQ:RWLK)

Buy ($175)

Proprietary Genome Editing Platforms

March 16, 2018

Companies covered: Sangamo Therapeutics, Inc. (NASDAQ:SGMO), Novartis AG (NYSE:NVS), Gilead Sciences, Inc. (NASDAQ:GILD), bluebird bio, Inc. (NASDAQ:BLUE), Cellectis S.A. (NASDAQ:CLLS), Monsanto Company (NYSE:MON), Illumina, Inc. (NASDAQ:ILMN), Foundation Medicine, Inc. (NASDAQ:FMI), CRISPR Therapeutics AG (NASDAQ:CRSP), uniQure N.V. (NASDAQ:QURE), Spark Therapeutics, Inc. (NASDAQ:ONCE), AveXis Inc (NASDAQ:AVXS), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Regenxbio Inc (NASDAQ:RGNX), Oxford BioMedica plc (LON:OXB), Editas Medicine (NASDAQ:EDIT), Intellia Therapeutics (NASDAQ:NTLA), GenSight Biologics SA (EPA:SIGHT), ToolGen (KONEX:199800), Lysogene SA (EPA:LYS), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Adaptimmune Therapeutics plc (NASDAQ:ADAP), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Intrexon Corporation (NYSE:XON), Pfizer, Inc. (NYSE:PFE), Celgene Corporation (NASDAQ:CELG), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Solid Biosciences (NASDAQ:SLDB), Rocket Pharmaceuticals (NASDAQ:RCKT), Audentes Therapeutics (NASDAQ:BOLD), Fibrocell Science Inc (NASDAQ:FCSC)

Buy ($175)

Biotechnology and Pharmaceuticals

March 08, 2018

Companies covered: Spero Therapeutics, Inc. (NASDAQ:SPRO), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Biogen Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Pfizer, Inc. (NYSE:PFE), AbbVie Inc. (NYSE:ABBV), Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM), Cellectis S.A. (NASDAQ:CLLS), Celsion Corporation (NASDAQ:CLSN), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Catabasis Pharmaceuticals Inc (NASDAQ:CATB), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Amgen Inc. (NASDAQ:AMGN), Gilead Sciences, Inc. (NASDAQ:GILD), Summit Therapeutics PLC (NASDAQ:SMMT), Spark Therapeutics, Inc. (NASDAQ:ONCE), Sage Therapeutics, Inc. (NASDAQ:SAGE), Achaogen Inc (NASDAQ:AKAO), Nabriva Therapeutics plc (NASDAQ:NBRV), Race Oncology Ltd. (ASX:RAC), Soligenix, Inc. (NASDAQ:SNGX), TiGenix (NASDAQ:TIG), Merck & Company, Inc. (NYSE:MRK), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), CRISPR Therapeutics AG (NASDAQ:CRSP), RXI Pharmaceuticals Corporation (NASDAQ:RXII), Oncolytics Biotech, Inc. (USA) (OTCMKTS:ONCYF), Cardiome Pharma Corporation (NASDAQ:CRME), Checkpoint Therapeutics Inc (NASDAQ:CKPT), Resverlogix Corp. (OTCMKTS:RVXCF), Illumina, Inc. (NASDAQ:ILMN), Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Buy ($175)

Biotechnology and Medical Research

November 03, 2017

Companies covered: Illumina, Inc. (NASDAQ:ILMN), Pacific Biosciences of California, Inc. (NASDAQ:PACB), Quidel Corporation (NASDAQ:QDEL), Meridian Bioscience Inc. (NASDAQ:VIVO), Bio-Rad Laboratories, Inc. (NYSE:BIO), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Danaher Corporation (NYSE:DHR), Thermo Fisher Scientific Inc (NYSE:TMO), Quest Diagnostics Incorporated (NYSE:DGX), Laboratory Corporation of America Holdings (NYSE:LH), IDEXX Laboratories, Inc. (NASDAQ:IDXX), Neogen Corporation (NASDAQ:NEOG), ABAXIS, Inc. (NASDAQ:ABAX), Heska Corporation (NASDAQ:HSKA), LHC Group (NASDAQ:LHCG), Amedisys Inc (NASDAQ:AMED), The Ensign Group, Inc. (NASDAQ:ENSG), HealthSouth Corporation (NYSE:HLS), CareTrust REIT, Inc. (NASDAQ:CTRE), Acadia Healthcare Company, Inc. (NASDAQ:ACHC), UnitedHealth Group Incorporated (NYSE:UNH), Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), Abbott Laboratories (NYSE:ABT), GenMark Diagnostics, Inc. (NASDAQ:GNMK), Luminex Corporation (NASDAQ:LMNX), BioMerieux SA (EPA:BIM), Accelerate Diagnostics, Inc. (NASDAQ:AXDX), EXACT Sciences Corporation (NASDAQ:EXAS), Glaukos Corp (NYSE:GKOS), Cooper Companies, Inc. (The) (NYSE:COO), Teleflex Incorporated (NYSE:TFX), Becton, Dickinson and Company (NYSE:BDX), Alere Inc. (NYSE:ALR), C.R. Bard, Inc. (NYSE:BCR), Hologic, Inc. (NASDAQ:HOLX), Masimo Corporation (NASDAQ:MASI), General Electric Company (NYSE:GE), Siemens AG (OTCMKTS:SIEGY), Fujifilm Sonosite Inc (NASDAQ:SONO), Allergan, Inc. (NYSE:AGN), Align Technology, Inc. (NASDAQ:ALGN), Trupanion, Inc. (NYSE:TRUP), Patterson Companies, Inc. (NASDAQ:PDCO), Henry Schein, Inc. (NASDAQ:HSIC), DENTSPLY International Inc. (NASDAQ:XRAY), Sientra, Inc. (NASDAQ:SIEN), Omega Healthcare Investors, Inc. (NYSE:OHI), Genesis Healthcare, Inc. (NYSE:GEN), Healthcare Trust of America, Inc. (NYSE:HTA), Welltower Inc (NYSE:HCN), Ventas, Inc. (NYSE:VTR), Healthcare Realty Trust Incorporated (NYSE:HR), Physicians Realty Trust (NYSE:DOC), Care Capital Properties, Inc. (NYSE:CCP), HCP, Inc. (NYSE:HCP), Quality Care Properties (NYSE:QCP), InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF), Anavex Life Sciences Corp. (NASDAQ:AVXL), Oasmia Pharmaceutical AB (NASDAQ:OASM), Innovotech Inc. (CVE:IOT), NeuroVive Pharmaceutical AB (OTCMKTS:NEVPF), Nuevolution AB (NUE.ST)

Buy ($175)

Health Care IT

October 06, 2017

Companies covered: CareDx, Inc. (NASDAQ:CDNA), Cerner Corporation (NASDAQ:CERN), Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), Quality Systems, Inc. (NASDAQ:QSII), athenahealth, Inc. (NASDAQ:ATHN), Evolent Health Inc. (NYSE:EVH), Cotiviti Holdings Inc (NYSE:COTV), HMS Holdings Corp (NASDAQ:HMSY), Stericycle, Inc. (NASDAQ:SRCL), Owens & Minor, Inc. (NYSE:OMI), Healthcare Services Group, Inc. (NASDAQ:HCSG), Premier, Inc. (NASDAQ:PINC), NantHealth (NASDAQ:NH), Teladoc Inc (NYSE:TDOC), HealthEquity, Inc. (NASDAQ:HQY), Express Scripts Holding Company (NASDAQ:ESRX), CVS Health Corporation (NYSE:CVS), Amazon.com, Inc. (NASDAQ:AMZN), Computer Programs and Systems, Inc. (NASDAQ:CPSI), Medidata Solutions, Inc. (NASDAQ:MDSO)

Buy ($175)